|
1.
|
A LonghiC ErraniM De PaolisPrimary bone OS
in the pediatric age: State of the artCancer Treatment
Reviews32423436200610.1016/j.ctrv.2006.05.00516860938
|
|
2.
|
R MckennaCP SchwinnKY SoongSarcomata of
the osteogenic series (osteosarcoma, fibrosarcoma, chondrosarcoma,
parosteal osteogenic sarcoma, and sarcomata arising in abnormal
bone) an analysis of 552 casesJ Bone Joint Surg481261966
|
|
3.
|
Y IwamotoK TanakaK IsuMultiinstitutional
phase II study of neoadjuvant chemotherapy for OS (NECO study) in
Japan: NECO-93J and NECO-95JJ Orthop
Sci14397404200910.1007/s00776-009-1347-619662473
|
|
4.
|
PA MeyersCL SchwartzM KrailoOS: A
randomized, prospective trial of the addition of ifosfamide and/or
muramyl tripeptide to cisplatin, doxorubicin, and high-dose
methotrexateJ Clin
Oncol2320042011200510.1200/JCO.2005.06.03115774791
|
|
5.
|
MU JawadMC CheungOsteosarcoma: improvement
in survival limited to high-grade patients onlyJ Cancer Res Clin
Oncol137597607201110.1007/s00432-010-0923-720514491
|
|
6.
|
V MialouT PhilipC KalifaMetastatic OS at
diagnosis: prognostic factors and long-term outcome - the French
pediatric experienceCancer10411001109200516015627
|
|
7.
|
M HegyiAF SemseiZ JakabGood prognosis of
localized OS in young patients treated with limb-salvage surgery
and chemotherapyPediatr Blood
Cancer57415422201110.1002/pbc.2317221563300
|
|
8.
|
MP StokkelMF LinthorstJJ BormA
reassessment of bone scintigraphy and commonly tested pretreatment
biochemical parameters in newly diagnosed osteosarcomaJ Cancer Res
Clin Oncol128393399200210.1007/s00432-002-0350-512136254
|
|
9.
|
PL AloM AminiF PiroImmunohistochemical
expression and prognostic significance of fatty acid synthase in
pancreatic carcinomaAnticancer Res2725232527200717695548
|
|
10.
|
T KusakabeA NashimotoK HonmaFatty acid
synthase is highly expressed in carcinoma, adenoma and in
regenerative epithelium and intestinal metaplasia of the
stomachHistopathology407179200210.1046/j.1365-2559.2002.01289.x11903600
|
|
11.
|
K WalterSM HongS NyhanSerum fatty acid
synthase as a marker of pancreatic neoplasiaCancer Epidemiol
Biomarkers
Prev1823802385200910.1158/1055-9965.EPI-09-014419723916
|
|
12.
|
Y OkawaT HideshimaH IkedaFatty acid
synthase is a novel therapeutic target in multiple myelomaBritish
Journal of
Haematology141659671200810.1111/j.1365-2141.2008.07114.x
|
|
13.
|
T MigitaS RuizA FornariFatty acid
synthase: a metabolic enzyme and candidate oncogene in prostate
cancerJ Natl Cancer
Inst101519532200910.1093/jnci/djp03019318631
|
|
14.
|
S YanW KefengSY ShengExpression of fatty
acid synthase in bladder transitional cell carcinoma and its
significanceChina Oncology173953972007
|
|
15.
|
SD SilvaIW CunhaRN YounesErbB receptors
and fatty acid synthase expression in aggressive head and neck
squamous cell carcinomasOral
Dis16774780201010.1111/j.1601-0825.2010.01687.x20604875
|
|
16.
|
P CrispinoPL AlòM RiveraEvaluation of
fatty acid synthase expressionin oesophageal mucosa of patients
with oesophagitis, Barrett’s oesophagus and adenocarcinomaJ Cancer
Res Clin Oncol13515331541200919471962
|
|
17.
|
H OritaJ CoulterE TullyInhibiting fatty
acid synthase for chemoprevention of chemically induced lung
tumorsClin Cancer
Res1424582464200810.1158/1078-0432.CCR-07-417718413838
|
|
18.
|
DT ColemanR BigelowJA CardelliInhibition
of fatty acid synthase by luteolin post-transcriptionally
down-regulates c-Met expression independent of proteosomal
lysosomal degradationMol Cancer
Ther8214224200910.1158/1535-7163.MCT-08-072219139131
|
|
19.
|
MA CarvalhoKG ZecchinF SeguinFatty acid
synthase inhibition with Orlistat promotes apoptosis and reduces
cell growth and lymph node metastasis in a mouse melanoma modelInt
J Cancer12325572565200810.1002/ijc.2383518770866
|
|
20.
|
S MurataK YanagisawaK FukunagaFatty acid
synthase inhibitor cerulenin suppresses liver metastasis of colon
cancer in miceCancer
Sci10118611865201010.1111/j.1349-7006.2010.01596.x20491775
|
|
21.
|
C LinLW MingLF BaoExpressions of P21(WAF1)
protein, CNA and Ki-67 and their significance in osteosarcomaChina
Oncology111091122001
|
|
22.
|
CS YehJY WangTL ChengFatty acid metabolism
pathway play an important role in carcinogenesis of human
colorectal cancers by Microarray Bioinformatics analysisCancer
Lett233297308200610.1016/j.canlet.2005.03.05015885896
|
|
23.
|
R FlavinS PelusoPL NguyenM LodaFatty acid
synthase as a potential therapeutic target in cancerFuture
Oncol6551562201210.2217/fon.10.1120373869
|
|
24.
|
T TakahiroK ShinichiS ToshimitsuExpression
of fatty acid synthase as a prognostic indicator in soft tissue
sarcomasClin Cancer Res922042212200312796387
|
|
25.
|
T KusakabeM MaedaN HoshiFatty acid
synthase is expressed mainly in adult hormone-sensitive cells or
cells with high lipid metabolism and in proliferating fetal cellsJ
Histochem
Cytochem48613622200010.1177/00221554000480050510769045
|
|
26.
|
JA MenendezR LupuFatty acid synthase and
the lipogenic phenotype in cancer pathogenesisNat Rev
Cancer7763777200710.1038/nrc222217882277
|
|
27.
|
S RossiW OuD TangGastrointestinal stromal
tumours overexpress fatty acid synthaseJ
Pathol209369375200610.1002/path.198316583360
|
|
28.
|
SD SilvaDE PerezIN NishimotoFatty acid
synthase expression in squamous cell carcinoma of the tongue:
clinicopathological findingsOral
Dis14376382200810.1111/j.1601-0825.2007.01395.x18410580
|
|
29.
|
PL AlòP ViscaML
FramarinoImmunohistochemical study of fatty acid synthase in
ovarian neoplasmsOncol Rep713831388200011032949
|
|
30.
|
K SelvendiranS AhmedA DaytonHO-3867, a
synthetic compound, inhibits the migration and invasion of ovarian
carcinoma cells through downregulation of fatty acid synthase and
focal adhesion kinaseMol Cancer
Res811881197201010.1158/1541-7786.MCR-10-0201
|
